the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
July 01, 2014 – As the knowledge of genetics and genomics rapidly expand, a personalized approach to health care is becoming increasingly important. India is fast becoming a promising contender in the global healthcare arena The majority of the global …
June 25, 2014 -The genetics startup 23andMe said on Friday it is one step closer to resuming sales of its full-fledged health product, with the U.S. Food and Drug Administration accepting its first health report for review. The home genetics …
Genetics Startup 23andMe takes Step on Path to FDA Approval Read more »
![The Apomediary [Patient Expert] and Personalized Medicine: A Commentary](https://thasso.com/wp-content/uploads/2014/06/Apomediary-II.png)
June 22, 2014 – The individuum (i.e., patient) is the phenotype expert on her/his individualized form of proper disease she/he is suffering from. It is not her/his treating physician, it is not a regulatory person concerned with the safety and …
The Apomediary [Patient Expert] and Personalized Medicine: A Commentary Read more »
June 20, 2014 – The genetic bad actor BRCA2 has been implicated in yet another cancer. The gene is known to increase risk for breast and ovarian cancers. Now, as a new genomic study shows, a rare variant of the …
Apple has unveiled HealthKit, a platform to centralise data from different types of devices, like fitness trackers, heart rate and blood pressure monitors. Launching iOS 8 for iPhones and iPads, which it describes as the biggest release since the launch …
May 31, 2014 – This article is from the latest issue of the ANL Magazine. – Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer …
Melanoma of the Eye Caused by Two Gene Mutations Read more »
May 23- 2014 – The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) caused by …
Dalbavancin (Dalvance): Approved by FDA to treat skin infections Read more »
May 22, 2014 – The U.S. Food and Drug Administration approved on May 20, 2014, Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease. Entyvio is approved to …
April 30, 2014 – The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Mekinist (trametinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E mutation. Mekinist …
![FDA approves the (ALK) tyrosine kinase inhibitor Ceritinib [Zykadia] for late-stage lung cancer](https://thasso.com/wp-content/uploads/2014/04/NSCLC-II.png)
April 30 , 2014 – The U.S. Food and Drug Administration yesterday granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC). Zykadia is an anaplastic lymphoma kinase (ALK) tyrosine kinase …